lifenews.com
2026-01-03
Few details are known about the new manufacturer expected to start selling its generic version of the abortion pill in January.
Evita Solutions' application was approved by the Food and Drug Administration (FDA) in September, despite earlier promises from administration officials that a review of the abortion pill was underway.
"Evita Solutions openly says its mission is to 'destigmatize abortion' and make abortions accessible 'for all,' yet very little is publicly known about the company now approved to manufacture and sell generic mifepristone," Susan B. Anthony Pro-Life America Director of Legal Affairs and Policy Counsel Katie Glenn Daniel told the Daily Caller News Foundation. "Its application was filed in October 2021, just months after the Biden FDA used COVID to eliminate the in-person doctor visit requirement for abortion drugs. It sat unapproved for more than 1,200 days under the Biden administration, yet was greenlit less than a year into the current administration."